Abbvie Cuts EPS
Abbvie sees Apogee deal hurting 2026 adjusted EPS by 14c/shr and 2027 adjusted EPS by 46c/shr
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Abbvie sees Apogee deal hurting 2026 adjusted EPS by 14c/shr and 2027 adjusted EPS by 46c/shr
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.